KBC Securities - BIOTALYS NV (BTLS) Morning Notes : BTLS BB

Report

KBC Securities

Guy Sips ...

Hilde Van Boxstael
Wim Lewi

Morning Notes : BTLS BB

: BTLS BB

24/05/2024 1 EN

Underlying

BIOTALYS NV

See profile

BE0974386188 Euronext Brussels Belgium

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Guy Sips

Hilde Van Boxstael

Wim Lewi

Other Reports on these Companies

KBC Securities

Biotech State of Affairs in Life Sciences

We provide an extensive overview on our life sciences coverage universe. The note covers recent updates, as well as upcoming catalysts, cash runway and estimates for these companies.

June 12, 2024 June 12, 2024 1 EN

KBC Securities

Biotalys A llama-inspired way to protect crops

Biotalys uses large molecule antibody technology from the pharmaceutical industry to develop innovative crop protection solutions. Its first product, the biofungicide Evoca, is derived from the AGROBODY Foundry platform and targets the high-growth biological crop protection market. Biotalys focuses on cost-effective R&D to introduce new modes of action in fungicides and insecticides, with regulatory processes in the US and EU progressing. It has commercial agreements in place for production and marketing and is managed by an experienced team. Recently, Biotalys transitioned to its second gene...

May 24, 2024 May 24, 2024 1 EN

Morning Notes : ARGX BB, BAR BB, DIE BB, ALFEN NA

: ARGX BB, BAR BB, DIE BB, ALFEN NA

3h / 2m 3h / 2m 1 EN

Michiel Declercq

Michiel Declercq

D'Ieteren Key highlights from the PHE strategy day & model update

Yesterday, PHE held a strategy day at its Logisteo distribution centre in Reau France, giving investors the opportunity to meet with PHE's management (CEO, CFO & COO) for the first time since the acquisition by D'Ieteren in 2022. As expected, no new financial targets were disclosed. However, during the presentation, the underlying growth drivers for the business were reiterated. Below, we summarize the key highlights. Additionally, we also slightly adjusted our D'Ieteren group estimates following the 1Q24 update (end-May). Although we have slightly tweaked our estimates to the downside due to ...

3h / 30m 3h / 30m 1 EN

Wim Hoste

Wim Hoste

Solvay Feedback Performance Chemicals webinar

Below are the highlights from the Performance Chemicals webinar which was held this morning. After the recent spun off of Syensqo, Solvay is a base chemicals group with leading market and technology positions in the vast majority of its businesses. The company will be managed with a conservative financial approach, favouring dividends over aggressive growth and operating with a solid balance sheet (1.4x leverage). The stable to growing dividend flow implies a solid 7% dividend yield. Other valuation ratios also look attractive and prompt us to reiterate our BUY rating and € 40 target price.

23h / 48m 23h / 48m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Morning Notes : BTLS BB

We are a financial services provider for several types of professional clients, each with distinct needs.

Biotech State of Affairs in Life Sciences

Biotalys A llama-inspired way to protect crops

Morning Notes : ARGX BB, BAR BB, DIE BB, ALFEN NA

D'Ieteren Key highlights from the PHE strategy day & model update

Solvay Feedback Performance Chemicals webinar

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe